Mechanism by which SepN modulates function of the RyR calcium release channel
SepN 调节 RyR 钙释放通道功能的机制
基本信息
- 批准号:8064275
- 负责人:
- 金额:$ 6.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-01 至 2012-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAffectAmino Acid SubstitutionApplications GrantsBindingCalciumCell physiologyCellsComplexCongenital AbnormalityCore ProteinCysteineDataDefectDevelopmentDiseaseDisulfidesElementsEmbryoEnvironmentEventExhibitsFeasibility StudiesFunctional disorderGene ExpressionGoalsHumanIn VitroLeftLinkLongitudinal StudiesMeasuresMediatingModelingModificationMolecular Mechanisms of ActionMuscleMuscle DevelopmentMuscle functionMutationMyocardiumMyopathyOxidation-ReductionOxidative StressOxidoreductasePathway interactionsPhysiologicalPhysiological ProcessesProcessProteinsPublishingReactionRegulationReportingResearch MethodologyResearch Project GrantsRoleRyR1RyanodineRyanodine Receptor Calcium Release ChannelSignal TransductionSiteSkeletal MuscleSolutionsStructureSulfhydryl CompoundsSulfidesTestingWorkZebrafishchemical reactionconflict resolutionexperiencein vivointercellular communicationmutantneural patterningoxidationpublic health relevancerelease of sequestered calcium ion into cytoplasmresponseselenoproteinsensor
项目摘要
DESCRIPTION (provided by applicant): The focus of this proposal is to test prevailing models of the molecular mechanism of action of Selenoprotein N (SepN). In humans, mutations that cause complete loss of SepN and mutations that affect the function of the RyR1 protein, the core protein component of the skeletal muscle Ryanodine Receptor intracellular Calcium Release Channel (RyR-CRC), result in congenital myopathies with a similar spectrum of cellular defects. Our recently published work (Jurynec, M. J. et al. (2008). "Selenoprotein N is required for ryanodine receptor calcium release channel activity in human and zebrafish muscle." PNAS 105: 12485-90.) identified SepN as a factor necessary for normal calcium mobilization in vivo and necessary for normal RyR- CRC function measured in vitro. RyR-CRCs isolated from zebrafish embryos or human diseased muscle lacking SepN no longer responded in vitro to changes in the solution redox environment indicating SepN as an essential component of the RyR-CRC redox sensor. Consistent with these findings, SepN has sequence motifs indicative of an oxidoreductase. As we found SepN physically associated with the RyR-CRC in vivo, we proposed that i) SepN interacts directly with the Calcium Release Channel, ii) SepN functions as a substrate- specific oxidoreductase that helps regulate activity of the CRC, and iii) defects in CRC function account for SepN-related myopathies. An alternative model has been recently set forth in which the primary function of SepN is to maintain the overall redox state of the cell and only indirectly affects muscle function (Arbogast, S. et al. (2009). "Oxidative stress in SEPN1-related myopathy: From pathophysiology to treatment." Ann Neurol 65: 677-686.). Our goal is to understand the mechanism by which SepN mediates the regulation of channel function as an entrance toward a broader understanding of how RyR-CRC activity may be regulated during normal development, perturbed in disease processes, or potentiated by treatments. The goal of this R03 "small grant" proposal is to test elements of our working hypothesis as an essential first step toward a longer-term study aimed at identifying i) the specific interactions between SepN and the RyR-CRC and ii) the specific RyR-CRC target sites modified by SepN activity. Here we will determine: Aim #1) if the redox function of SepN is required for normal RyR-CRC function, and Aim #2) if the RyR-CRC is a direct target of the SepN redox reaction. Understanding the function of SepN will identify pathways or physiological states required for normal muscle development and function. More specifically, if our working model is correct, understanding SepN function will identify a key mechanism by which calcium mobilization can be regulated in multiple cell signaling and cell physiology contexts.
PUBLIC HEALTH RELEVANCE: Mutations that completely block expression or function of Selenoprotein N (SepN) cause birth defects affecting muscle development and function. Mutations affecting the intracellular Calcium Release Channel cause similar birth defects. Our recent studies indicate that SepN that helps regulate Calcium Release Channel function, explaining why loss of either factor has a common effect. The focus of this proposal is to understand the mechanism by which SepN regulates channel function as an entrance toward a broader understanding of how Calcium Release Channel activity may be regulated during normal development, perturbed in disease processes, or potentiated by treatments.
DESCRIPTION (provided by applicant): The focus of this proposal is to test prevailing models of the molecular mechanism of action of Selenoprotein N (SepN). In humans, mutations that cause complete loss of SepN and mutations that affect the function of the RyR1 protein, the core protein component of the skeletal muscle Ryanodine Receptor intracellular Calcium Release Channel (RyR-CRC), result in congenital myopathies with a similar spectrum of cellular defects. Our recently published work (Jurynec, M. J. et al. (2008). "Selenoprotein N is required for ryanodine receptor calcium release channel activity in human and zebrafish muscle." PNAS 105: 12485-90.) identified SepN as a factor necessary for normal calcium mobilization in vivo and necessary for normal RyR- CRC function measured in vitro. RyR-CRCs isolated from zebrafish embryos or human diseased muscle lacking SepN no longer responded in vitro to changes in the solution redox environment indicating SepN as an essential component of the RyR-CRC redox sensor. Consistent with these findings, SepN has sequence motifs indicative of an oxidoreductase. As we found SepN physically associated with the RyR-CRC in vivo, we proposed that i) SepN interacts directly with the Calcium Release Channel, ii) SepN functions as a substrate- specific oxidoreductase that helps regulate activity of the CRC, and iii) defects in CRC function account for SepN-related myopathies. An alternative model has been recently set forth in which the primary function of SepN is to maintain the overall redox state of the cell and only indirectly affects muscle function (Arbogast, S. et al. (2009). "Oxidative stress in SEPN1-related myopathy: From pathophysiology to treatment." Ann Neurol 65: 677-686.). Our goal is to understand the mechanism by which SepN mediates the regulation of channel function as an entrance toward a broader understanding of how RyR-CRC activity may be regulated during normal development, perturbed in disease processes, or potentiated by treatments. The goal of this R03 "small grant" proposal is to test elements of our working hypothesis as an essential first step toward a longer-term study aimed at identifying i) the specific interactions between SepN and the RyR-CRC and ii) the specific RyR-CRC target sites modified by SepN activity. Here we will determine: Aim #1) if the redox function of SepN is required for normal RyR-CRC function, and Aim #2) if the RyR-CRC is a direct target of the SepN redox reaction. Understanding the function of SepN will identify pathways or physiological states required for normal muscle development and function. More specifically, if our working model is correct, understanding SepN function will identify a key mechanism by which calcium mobilization can be regulated in multiple cell signaling and cell physiology contexts.
PUBLIC HEALTH RELEVANCE: Mutations that completely block expression or function of Selenoprotein N (SepN) cause birth defects affecting muscle development and function. Mutations affecting the intracellular Calcium Release Channel cause similar birth defects. Our recent studies indicate that SepN that helps regulate Calcium Release Channel function, explaining why loss of either factor has a common effect. The focus of this proposal is to understand the mechanism by which SepN regulates channel function as an entrance toward a broader understanding of how Calcium Release Channel activity may be regulated during normal development, perturbed in disease processes, or potentiated by treatments.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JONATHAN J ABRAMSON其他文献
JONATHAN J ABRAMSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JONATHAN J ABRAMSON', 18)}}的其他基金
Rational Design of New Drugs to Treat Ventricular Arrhythmias
治疗室性心律失常新药的合理设计
- 批准号:
8314794 - 财政年份:2012
- 资助金额:
$ 6.95万 - 项目类别:
Mechanism by which SepN modulates function of the RyR calcium release channel
SepN 调节 RyR 钙释放通道功能的机制
- 批准号:
7978975 - 财政年份:2010
- 资助金额:
$ 6.95万 - 项目类别:
Redox Control of Sarcoplasmic Reticulum Calcium Release
肌浆网钙释放的氧化还原控制
- 批准号:
6649139 - 财政年份:2002
- 资助金额:
$ 6.95万 - 项目类别:
Redox Control of Sarcoplasmic Reticulum Calcium Release
肌浆网钙释放的氧化还原控制
- 批准号:
6776506 - 财政年份:2002
- 资助金额:
$ 6.95万 - 项目类别:
Redox Control of Sarcoplasmic Reticulum Calcium Release
肌浆网钙释放的氧化还原控制
- 批准号:
7110984 - 财政年份:2002
- 资助金额:
$ 6.95万 - 项目类别:
Redox Control of Sarcoplasmic Reticulum Calcium Release
肌浆网钙释放的氧化还原控制
- 批准号:
6925338 - 财政年份:2002
- 资助金额:
$ 6.95万 - 项目类别:
Redox Control of Sarcoplasmic Reticulum Calcium Release
肌浆网钙释放的氧化还原控制
- 批准号:
6522151 - 财政年份:2002
- 资助金额:
$ 6.95万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 6.95万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 6.95万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 6.95万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 6.95万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 6.95万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 6.95万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 6.95万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 6.95万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 6.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 6.95万 - 项目类别:
Studentship














{{item.name}}会员




